2005
DOI: 10.1016/j.jinsphys.2004.11.017
|View full text |Cite
|
Sign up to set email alerts
|

PBAN selective antagonists: inhibition of PBAN induced cuticular melanization and sex pheromone biosynthesis in moths

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2007
2007
2019
2019

Publication Types

Select...
4
3
1

Relationship

1
7

Authors

Journals

citations
Cited by 21 publications
(3 citation statements)
references
References 65 publications
0
3
0
Order By: Relevance
“…Here we report, for the first time, the expression and characterization of another PBAN-R, which is expressed in the larval stage and which most likely, is the receptor involved in other PK/PBAN functions during the insect larval stage, such as cuticular melanization (Ben-Aziz et al, 2005) or potential regulation of pupal diapause (Sun et al, 2005;Xu and Denlinger, 2003). Diapause is an adaptive stage in which the insects temporarily stagnate, in order to survive an unfavorable environmental condition.…”
Section: Discussionmentioning
confidence: 96%
“…Here we report, for the first time, the expression and characterization of another PBAN-R, which is expressed in the larval stage and which most likely, is the receptor involved in other PK/PBAN functions during the insect larval stage, such as cuticular melanization (Ben-Aziz et al, 2005) or potential regulation of pupal diapause (Sun et al, 2005;Xu and Denlinger, 2003). Diapause is an adaptive stage in which the insects temporarily stagnate, in order to survive an unfavorable environmental condition.…”
Section: Discussionmentioning
confidence: 96%
“…The PK/PBAN family of neuropeptides elicits a broad array of physiological activities in insect bioassays, including pheromonotropic (1-5), cuticular melanization (15,16), pupariation (26), and hindgut myotropic (1,28) in a variety of insects. In each of these assays, the active core, the minimum sequence capable of eliciting significant activity, has been identified as the C-terminal pentapeptide FXPRLa (X = S,T,G or V) that defines the PK/PBAN family (29)(30)(31)(32)(33)(34).…”
Section: Discussionmentioning
confidence: 99%
“…These results showed that BomPBANR recognizes the amino acid residue at C6 position and type I β-turn secondary structure (Nachman et al, 1993). We also synthesized and examined a peptide substituted with d -Phe at C4 position [RYFdFPRLamide, LA-4] which had been reported as a linear antagonist (Zeltser et al, 2000; Ben-Aziz et al, 2005) and demonstrated that LA-4 was a partial agonist to BomPBANR (Kawai et al, 2009). …”
Section: Introductionmentioning
confidence: 99%